Synthesis and Solid State Pharmaceutical Centre (SSPC), Bernal Institute, University of Limerick, Limerick, Ireland.
Synthesis and Solid State Pharmaceutical Centre (SSPC), Bernal Institute, University of Limerick, Limerick, Ireland.
J Control Release. 2018 Aug 10;283:1-19. doi: 10.1016/j.jconrel.2018.05.024. Epub 2018 May 23.
Patient compliance will soon become one of the most critical challenges in modern healthcare. Due in part to our aging population, the rise in the number of chronic conditions will cause increasing stress on global healthcare systems, magnifying current problems. The solutions employed to improve compliance have failed to deliver and the medical community have turned to Multidrug Formulations (MDFs), to provide an answer. This work summarises key challenges and subsequent solutions developed by formulation scientists when designing new MDFs, examining their rationale and highlighting successes to-date. Current and emerging MDF strategies are reviewed alongside a discussion of how the scientific community can bring these ideas from the benchtop to the clinic. Examples have been highlighted where teams have delivered scientific novelty, but a lack of clinical appreciation reduces their likelihood of patient impact. Potential gaps within the literature are identified where new, novel or modernised approaches could make a significant impact on patients.
患者依从性将很快成为现代医疗保健中最具挑战性的问题之一。部分原因是由于人口老龄化,慢性病患者人数的增加将给全球医疗体系带来更大的压力,从而加剧目前的问题。为提高患者依从性而采用的解决方案未能奏效,医学界转而采用多药物制剂(MDF)来寻求答案。这项工作总结了制剂科学家在设计新的 MDF 时遇到的关键挑战和随后开发的解决方案,探讨了其基本原理并强调了迄今为止的成功案例。本文还回顾了当前和新兴的 MDF 策略,并讨论了科学界如何将这些想法从实验室带到临床。本文还强调了一些团队在提供科学新颖性方面的例子,但由于缺乏临床认识,这些例子降低了它们对患者的影响的可能性。本文还确定了文献中的潜在差距,在这些差距中,新的、新颖的或现代化的方法可能会对患者产生重大影响。